Doximity (NYSE:DOCS) Stock Jumps 6.9% - What's Next?

Key Points

• Doximity shares rose 6.9% to $28.34 despite a broader market decline, indicating relative strength, although no new fundamental catalyst was identified.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $31.95; targets range from $18 to $41.
• The company beat quarterly EPS estimates ($0.29 versus $0.16) and grew revenue 7.3% year over year, but faces securities-fraud allegations related to market-share losses and competitive pricing—claims that remain unproven.

Shares of Doximity, Inc. (NYSE:DOCS - Get Free Report) shot up 6.9% during mid-day trading on Wednesday. The company traded as high as $28.25 and last traded at $28.34. Approximately 1,223,550 shares were traded during trading, a decline of 70% from the average daily volume of 4,011,666 shares. The stock had previously closed at $26.52.

Doximity News Roundup

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity recently gained while the broader market declined, suggesting relative strength and possible buying interest after prior weakness. The available market commentary did not identify a new fundamental catalyst. Doximity Gains As Market Dips
• Neutral Sentiment: Multiple law firms—including Kaplan Fox, Robbins Geller, Rosen, Pomerantz, Wolf Haldenstein and others—are soliciting investors to participate in or seek lead-plaintiff status in a securities class action. The notices largely repeat the same allegations and November 16, 2026 deadline rather than announcing a new court ruling. Kaplan Fox Doximity Investor Alert
• Negative Sentiment: The lawsuit alleges that Doximity and certain executives made false or misleading statements between August 8, 2024, and May 13, 2026, including claims that the company could gain market share while competitors offered more favorable pricing and engagement models. Other allegations involve traditional advertising formats losing ground to programmatic and social-media competitors. These claims remain allegations and could expose Doximity to legal costs, reputational damage and potential financial liability. Robbins LLP Doximity Investigation

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Canaccord Genuity Group set a $36.00 price target on shares of Doximity in a report on Friday, August 7th. Wells Fargo & Company downgraded Doximity from an "equal weight" rating to an "underweight" rating and set a $18.00 price objective on the stock. in a report on Monday, August 10th. Barclays increased their price objective on Doximity from $20.00 to $27.00 and gave the company an "equal weight" rating in a research report on Friday, August 21st. Stifel Nicolaus set a $27.00 target price on Doximity in a research note on Tuesday, September 8th. Finally, Needham & Company LLC restated a "buy" rating and set a $41.00 target price on shares of Doximity in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $31.95.

Doximity Stock Performance

The firm's 50-day simple moving average is $24.72 and its 200 day simple moving average is $23.17. The company has a market cap of $5.03 billion, a P/E ratio of 33.23, a PEG ratio of 20.49 and a beta of 1.25.

Doximity (NYSE:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The company had revenue of $156.62 million for the quarter. During the same period last year, the company earned $0.36 EPS. The business's revenue for the quarter was up 7.3% compared to the same quarter last year. As a group, research analysts forecast that Doximity, Inc. will post 0.74 earnings per share for the current year.

Insider Buying and Selling at Doximity

In other news, Director Kira Wampler sold 2,000 shares of the business's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $24.95, for a total transaction of $49,900.00. Following the completion of the transaction, the director directly owned 19,839 shares in the company, valued at approximately $494,983.05. The trade was a 9.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Timothy S. Cabral sold 7,500 shares of the company's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $39.11, for a total value of $293,325.00. Following the completion of the sale, the director directly owned 3,221 shares of the company's stock, valued at approximately $125,973.31. This trade represents a 69.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 13,347 shares of company stock valued at $441,412. 31.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC raised its holdings in Doximity by 111.0% in the first quarter. Parallel Advisors LLC now owns 2,560 shares of the company's stock worth $60,000 after purchasing an additional 1,347 shares during the period. EverSource Wealth Advisors LLC increased its position in shares of Doximity by 937.7% in the 1st quarter. EverSource Wealth Advisors LLC now owns 2,833 shares of the company's stock valued at $66,000 after buying an additional 2,560 shares in the last quarter. Continuum Advisory LLC acquired a new stake in Doximity during the 2nd quarter worth $67,000. Leonteq Securities AG lifted its holdings in Doximity by 65.6% during the first quarter. Leonteq Securities AG now owns 2,912 shares of the company's stock worth $68,000 after acquiring an additional 1,154 shares in the last quarter. Finally, Nykredit A S acquired a new position in Doximity in the second quarter valued at about $96,000. Institutional investors own 87.19% of the company's stock.

About Doximity

Doximity, Inc operates a digital platform for U.S. medical professionals. Its network enables physicians and other healthcare providers to communicate, collaborate, access medical news and research, maintain professional profiles, and connect with colleagues and patients.

The company offers a range of tools for healthcare organizations and professionals, including telehealth services, digital faxing, scheduling and communication products, and solutions for recruiting and marketing. Doximity also provides pharmaceutical and healthcare companies with digital engagement services designed to reach medical professionals through its platform.

Founded in 2010, Doximity is headquartered in San Francisco and primarily serves the United States healthcare market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.